A detailed history of Greenwood Capital Associates LLC transactions in Danaher Corp stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 33,526 shares of DHR stock, worth $7.74 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
33,526
Previous 27,967 19.88%
Holding current value
$7.74 Million
Previous $6.99 Million 33.38%
% of portfolio
1.24%
Previous 0.94%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$239.25 - $280.76 $1.33 Million - $1.56 Million
5,559 Added 19.88%
33,526 $9.32 Million
Q2 2024

Aug 08, 2024

BUY
$235.51 - $267.98 $2.18 Million - $2.48 Million
9,248 Added 49.4%
27,967 $6.99 Million
Q1 2024

May 01, 2024

BUY
$224.58 - $256.19 $3.26 Million - $3.72 Million
14,536 Added 347.5%
18,719 $4.67 Million
Q4 2023

Mar 05, 2024

SELL
$185.1 - $233.13 $7,404 - $9,325
-40 Reduced 0.95%
4,183 $967,000
Q3 2023

Oct 18, 2023

SELL
$233.08 - $265.59 $18,879 - $21,512
-81 Reduced 1.88%
4,223 $1.05 Million
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $48,669 - $56,231
-203 Reduced 4.5%
4,304 $1.08 Million
Q2 2022

Aug 10, 2022

BUY
$237.11 - $299.66 $1.05 Million - $1.33 Million
4,434 Added 6073.97%
4,507 $1.14 Million
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $1.14 Million - $1.4 Million
-4,449 Reduced 98.39%
73 $21,000
Q4 2021

Feb 03, 2022

BUY
$292.08 - $329.01 $26,579 - $29,939
91 Added 2.05%
4,522 $1.49 Million
Q4 2020

Feb 09, 2021

SELL
$212.5 - $245.46 $31,025 - $35,837
-146 Reduced 3.19%
4,431 $985,000
Q3 2020

Nov 12, 2020

BUY
$177.16 - $215.33 $19,487 - $23,686
110 Added 2.46%
4,577 $986,000
Q3 2019

Nov 12, 2019

BUY
$135.4 - $146.47 $604,831 - $654,281
4,467 New
4,467 $645,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.